Rxsight, Inc. rose 1.64% in premarket trading, with the company announcing the appointment of Raymond W. Cohen to its Board of Directors. The appointment is expected to bring valuable insights and guidance to the company as it advances its strategy and enters the next phase of growth.
Comments
No comments yet